CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-22 | Fong Bryant Director | Sale | −1,433,304 | $3.87 | $5.5M | 0 |
| 2023-08-18 | Grossman Adam S President and CEO | Sale | −250,000 | $4.15 | $1.0M | 2,273,085 |
| 2023-08-16 | Grossman Adam S President and CEO | Sale | −3 | $4.39 | $13 | 2,523,085 |
| 2023-08-16 | LENZ BRIAN EVP, CFO | Sale | −178,184 | $4.45 | $793K | 782,013 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +212,500 | $1.67 | $355K | 2,735,585 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +277,131 | $2.35 | $651K | 3,012,716 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +277,604 | $2.92 | $809K | 3,290,320 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +400,000 | $3.22 | $1.3M | 3,690,320 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +350,000 | $3.71 | $1.3M | 4,040,320 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise | +583,224 | $3.66 | $2.1M | 4,623,544 |
| 2023-08-15 | Grossman Adam S President and CEO | Sale | −510,469 | $4.54 | $2.3M | 4,113,075 |
| 2023-08-15 | Grossman Adam S President and CEO | Shares withheld for taxes | −1,589,987 | $4.61 | $7.3M | 2,523,088 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −212,500 | $1.67 | $355K | 387,500 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −277,131 | $2.35 | $651K | 181,569 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −277,604 | $2.92 | $809K | 47,396 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −400,000 | $3.22 | $1.3M | 0 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −350,000 | $3.71 | $1.3M | 0 |
| 2023-08-15 | Grossman Adam S President and CEO | Option exercise · Common Stock | −583,224 | $3.66 | $2.1M | 0 |
| 2023-08-15 | LENZ BRIAN EVP, CFO | Sale | −211,578 | $4.60 | $973K | 782,013 |
| 2023-08-15 | LENZ BRIAN EVP, CFO | Option exercise | +97,395 | $1.67 | $163K | 879,408 |
Page 14 of 31 · 618 trades